1. Home
  2. ESOA vs MOLN Comparison

ESOA vs MOLN Comparison

Compare ESOA & MOLN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Energy Services of America Corporation

ESOA

Energy Services of America Corporation

HOLD

Current Price

$12.56

Market Cap

136.2M

Sector

Industrials

ML Signal

HOLD

Logo Molecular Partners AG

MOLN

Molecular Partners AG

HOLD

Current Price

$4.22

Market Cap

158.9M

Sector

N/A

ML Signal

HOLD

Company Overview

Basic Information
Metric
ESOA
MOLN
Founded
2006
2004
Country
United States
Switzerland
Employees
N/A
N/A
Industry
Water Sewer Pipeline Comm & Power Line Construction
Sector
Industrials
Exchange
Nasdaq
Nasdaq
Market Cap
136.2M
158.9M
IPO Year
2006
2021

Fundamental Metrics

Financial Performance
Metric
ESOA
MOLN
Price
$12.56
$4.22
Analyst Decision
Strong Buy
Buy
Analyst Count
1
2
Target Price
$21.00
$8.38
AVG Volume (30 Days)
309.3K
2.1K
Earning Date
05-20-2026
01-01-0001
Dividend Yield
0.94%
N/A
EPS Growth
N/A
N/A
EPS
0.16
N/A
Revenue
$122,465,826.00
N/A
Revenue This Year
$9.22
N/A
Revenue Next Year
$3.77
$285.71
P/E Ratio
$79.81
N/A
Revenue Growth
2.74
N/A
52 Week Low
$7.64
$3.36
52 Week High
$15.84
$5.36

Technical Indicators

Market Signals
Indicator
ESOA
MOLN
Relative Strength Index (RSI) 43.74 32.57
Support Level $8.56 $4.02
Resistance Level $15.84 $4.61
Average True Range (ATR) 0.79 0.22
MACD -0.45 -0.09
Stochastic Oscillator 2.44 0.00

Price Performance

Historical Comparison
ESOA
MOLN

About ESOA Energy Services of America Corporation

Energy Services of America Corporation is engaged in providing contracting services for energy-related companies. The company is predominantly engaged in the construction, replacement, and repair of natural gas pipelines and storage facilities for utility companies and private natural gas companies. It services the gas, petroleum, power, chemical, and automotive industries and does incidental work such as water and sewer projects. Energy Service's other services include liquid pipeline construction, pump station construction, production facility construction, water and sewer pipeline installations, various maintenance and repair services, and other services related to pipeline construction.

About MOLN Molecular Partners AG

Molecular Partners AG is a clinical stage biopharmaceutical company. The Company has programs in various stages of pre-clinical and clinical development, with oncology as its main focus. The firm develops protein therapeutics called DARPin therapeutics for the treatment of serious diseases, including cancer and sight-threatening disorders. The company's product pipeline is organized principally through three areas: Ophthalmology, including the creation of therapies for retinal diseases like wet age-related macular degeneration and diabetic macular edema; the Oncology pipeline comprises DARPin candidates with novel modes of action, including multi-DARPin compounds; and Immuno-oncology for anticancer treatment.

Share on Social Networks: